Literature DB >> 27111137

Control of primary lesions using resection or radiotherapy can improve the prognosis of metastatic colorectal cancer patients.

Takahiro Takada1, Soichi Tsutsumi1, Ryo Takahashi1, Katsuya Ohsone1, Hironori Tatsuki1, Toshinaga Suto1, Toshihide Kato1, Takaaki Fujii1, Takehiko Yokobori2, Hiroyuki Kuwano1.   

Abstract

BACKGROUND: Control of the primary lesions in metastatic colorectal cancer (mCRC) is still controversial. For rectal cancer patients, not only resection but also irradiation is expected to provide palliative effects. We investigated the effects of resection and irradiation of primary lesions (local control) on the prognosis of mCRC patients. PATIENTS: Forty-seven patients with mCRC at our institute were examined, with 34 in the local controlled group and 13 in the uncontrolled group.
RESULTS: The median survival time (MST) of the local controlled and uncontrolled groups were 2.90 and 1.39 years (P = 0.028). Cox proportional hazard regression analysis showed that local control was an independent prognostic factor (P < 0.05). The patients who underwent primary lesion resection had significantly longer MST (2.90 vs. 1.39 years, P = 0.032) than those in the uncontrolled group. In rectal cancer patients, the patients who underwent irradiation to control the primary lesions had a significantly longer MST than the uncontrolled patient group (1.97 vs. 1.39 years, P = 0.019).
CONCLUSIONS: Local control of primary lesions may improve the prognosis in mCRC patients. In rectal cancer patients with metastasis, not only resection but also irradiation of the primary lesions may be a useful therapeutic strategy. J. Surg. Oncol. 2016;114:75-79.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  metastatic colorectal cancer; primary lesion; radiotherapy; surgical resection

Mesh:

Year:  2016        PMID: 27111137     DOI: 10.1002/jso.24255

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  8 in total

1.  The influence of local therapy on the survival of patients with metastatic rectal cancer: a population-based, propensity-matched study.

Authors:  Chi-Hao Zhang; Yuan-Bo Pan; Qing-Wei Zhang; Ou-Min Shi; Lei Zheng; Liang Gui; Meng Luo
Journal:  J Cancer Res Clin Oncol       Date:  2017-05-22       Impact factor: 4.553

2.  Primary Tumor Resection in Patients with Incurable Localized or Metastatic Colorectal Cancer: A Systematic Review and Meta-analysis.

Authors:  Constantinos Simillis; Eliana Kalakouti; Thalia Afxentiou; Christos Kontovounisios; Jason J Smith; David Cunningham; Michel Adamina; Paris P Tekkis
Journal:  World J Surg       Date:  2019-07       Impact factor: 3.352

Review 3.  A Concise Review of Pelvic Radiation Therapy (RT) for Rectal Cancer with Synchronous Liver Metastases.

Authors:  Omer Sager; Ferrat Dincoglan; Selcuk Demiral; Bora Uysal; Hakan Gamsiz; Bahar Dirican; Murat Beyzadeoglu
Journal:  Int J Surg Oncol       Date:  2019-04-21

4.  Survival Benefit of Preoperative Versus Postoperative Radiotherapy in Metastatic Rectal Cancer Treated With Definitive Surgical Resection of Primary Tumor: A Population Based, Propensity Score-Matched Study.

Authors:  Dakui Luo; Qi Liu; Ji Zhu; Yanlei Ma; Sanjun Cai; Qingguo Li; Xinxiang Li
Journal:  J Cancer       Date:  2019-01-30       Impact factor: 4.207

5.  A competing-risk nomogram to predict cause-specific death in elderly patients with colorectal cancer after surgery (especially for colon cancer).

Authors:  Zhengbing Wang; Yawei Wang; Yan Yang; Yi Luo; Jiangtao Liu; Yingjie Xu; Xuan Liu
Journal:  World J Surg Oncol       Date:  2020-02-04       Impact factor: 2.754

6.  Individualized prediction of survival benefit from primary tumor resection for patients with unresectable metastatic colorectal cancer.

Authors:  Yi Yang; Yujie Lu; Wen Jiang; Jinzhou Zhu; Su Yan
Journal:  World J Surg Oncol       Date:  2020-08-03       Impact factor: 2.754

7.  Surgery of primary tumor improves the survival of newly diagnosed metastatic melanoma: a population-based, propensity-matched study.

Authors:  Dongxiao Zhang; Yinjun Dong; Xiubin Sun; Shuanghu Yuan; Jinming Yu
Journal:  Cancer Manag Res       Date:  2018-12-27       Impact factor: 3.989

8.  Surgery improves the prognosis of colon mucinous adenocarcinoma with liver metastases: a SEER-based study.

Authors:  Jia Huang; Guodong Chen; Huan Liu; Yiwei Zhang; Rong Tang; Qiulin Huang; Kai Fu; Xiuda Peng; Shuai Xiao
Journal:  BMC Cancer       Date:  2020-09-23       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.